Looking to advance the discovery and development of therapeutics, Structural GenomiX Inc. and the Hereditary Disease Foundation entered a collaboration to use SGX's structure-directed drug discovery technologies to investigate the structure of the protein responsible for Huntington's disease. (BioWorld Today)
Looking to advance the discovery and development of therapeutics, Structural GenomiX Inc. and the Hereditary Disease Foundation entered a collaboration to use SGX's structure-directed drug discovery technologies to investigate the structure of the protein responsible for Huntington's disease. (BioWorld Today)
Monday marked the start of a watershed week for Idun Pharmaceuticals Inc., which closed a $22.8 million preferred stock private placement financing concurrent with the Nobel Prize ceremony, at which the chairman of its scientific advisory board is being honored. (BioWorld Today)
Monday marked the start of a watershed week for Idun Pharmaceuticals Inc., which closed a $22.8 million preferred stock private placement financing concurrent with the Nobel Prize ceremony, at which the chairman of its scientific advisory board is being honored. (BioWorld Today)
Curis Inc. last week shed certain assets as part of an ongoing realignment, while licensing out its second program in about a week's time and simultaneously cutting jobs. (BioWorld Today)
Curis Inc. last week shed certain assets as part of an ongoing realignment, while licensing out its second program in about a week's time and simultaneously cutting jobs. (BioWorld Today)
Its science rooted deep in North Carolina tobacco country, Targacept Inc. continues to impress observers with its neuronal nicotinic receptor approach to drug discovery. (BioWorld Today)
Its science rooted deep in North Carolina tobacco country, Targacept Inc. continues to impress observers with its neuronal nicotinic receptor approach to drug discovery. (BioWorld Today)
